0:00
NaN:NaN:NaN
FDA medical oncologists discuss the July 7, 2017, approval of l-glutamine to reduce the acute complications of sickle cell disease.
Released August 17, 2017
More episodes from "FDA Drug Information Updates"
Don't miss an episode of “FDA Drug Information Updates” and subscribe to it in the GetPodcast app.